GlobeNewswire by notified

Shareholders approve all resolutions on the agendas of Tenaris’s Annual General Meeting and Extraordinary General Meeting of Shareholders

Share

LUXEMBOURG, May 01, 2024 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) announced that its annual general meeting of shareholders and its extraordinary general meeting of shareholders, both held on April 30, 2024, approved all resolutions on their agendas.

Among other resolutions adopted at the annual general meeting, shareholders acknowledged the Company’s 2023 annual report, containing the consolidated management report and the related management certifications and external auditors’ reports, and the Company’s 2023 annual sustainability report, containing the non-financial statement required by Luxembourg law. The shareholders also approved the consolidated financial statements as of and for the year ended December 31, 2023, and the annual accounts as at December 31, 2023.

The annual general meeting also approved an annual dividend of US$0.60 per share (or US$1.20 per ADR), which represents an aggregate sum of approximately US$0.7 billion, and which includes the interim dividend of US$0.20 per share (US$0.40 per ADR), or approximately US$235 million, paid in November 2023. Tenaris will pay the balance of the annual dividend in the amount of US$0.40 per share entitled to dividends (or US$0.80 per ADR), in U.S. dollars, which represents approximately US$459 million, on May 22, 2024, with an ex-dividend date of May 20, 2024, and record date of May 21, 2024.

The shareholders resolved to set the number of directors in eleven and approved the re-appointment of Mr. Simon Ayat, Mr. Roberto Bonatti, Mr. Carlos Condorelli, Mr. Germán Curá, Ms. Maria Novales-Flamarique, Mr. Gianfelice Mario Rocca, Mr. Paolo Rocca, Mr. Jaime Serra Puche, Ms. Monica Tiuba and Mr. Guillermo Vogel, and the appointment of Ms. Molly Montgomery as new director. All board members will hold office until the meeting that will be convened to decide on the 2024 annual accounts. In a subsequent meeting, the board of directors re-elected Mr. Simon Ayat, Mr. Jaime Serra Puche and Ms. Monica Tiuba as audit committee members, with Ms. Tiuba continuing to serve as the committee’s chair. All members of the audit committee qualify as independent directors for purposes of the U.S. Securities Exchange Act Rule 10A-3(b)(1) and under the Company’s articles of association.  

In addition, the annual general meeting approved the compensation payable to the members of the Board for the year ending December 31, 2024, the Compensation Report for the year 2023 and a revised Compensation Policy, applicable to the Company’s directors and the chief executive officer, effective as from the year 2024. The meeting also approved Ernst & Young’s fees for the fiscal year ending December 31, 2024.

The extraordinary general meeting of shareholders held immediately after the annual general meeting, resolved to approve the cancellation of 17,779,302 ordinary shares held in treasury by the Company acquired throughout the first tranche of its share buyback program and resolved to approve the corresponding reduction of the issued share capital of the Company and the amendment of the first paragraph of article 5 of the Company’s articles of association. As a result, effective April 30, 2024, the share capital of the Company is reduced from US$1,180,536,830 (represented by 1,180,536,830 shares with a par value of US$1 per share) to US$1,162,757,528 (represented by 1,162,757,528 shares with a par value of US$1 per share).

Copies of the minutes of the annual general meeting and extraordinary general meeting, and copy of the amended articles of association can be downloaded from Tenaris’s website at ir.tenaris.com/corporate-governance/annual-general-meeting.

Tenaris is a leading global supplier of steel tubes and related services for the world’s energy industry and certain other industrial applications.

Giovanni Sardagna
Tenaris
1-888-300-5432
www.tenaris.com


To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash16.5.2024 11:27:34 CEST | Press release

Novartis secured 79.6 percent acceptance by MorphoSys shareholders during the initial acceptance period, reaching the minimum 65% acceptance thresholdSettlement of the shares tendered during the initial acceptance period is expected to occur on 23 May 2024Additional statutory acceptance period is expected to end on 30 May 2024 at 24:00 hours CESTTransaction strengthens the Novartis pipeline in oncology, adding pelabresib, a late-stage BET inhibitor for myelofibrosis and tulmimetostat, an early-stage investigational dual inhibitor of EZH2 and EZH1 for solid tumors or lymphomas Basel, 16 May 2024 – Today, Novartis BidCo AG, an (indirect) wholly owned subsidiary of Novartis AG, announced the result of its voluntary public takeover offer (the “Offer”) for the shares of MorphoSys AG (“MorphoSys”), including all shares represented by MorphoSys American Depositary Shares (“ADS”). As of the expiry of the acceptance period at 24:00 hours CEST on 13 May 2024, the Offer has been accepted by appro

Havila Kystruten AS: Innkalling til ordinær generalforsamling 30 mai 202416.5.2024 11:19:34 CEST | Pressemelding

Styret i Havila Kystruten AS kaller inn til ordinær generalforsamling. Generalforsamlingen avholdes torsdag 30. mai 2024 kl 14:00. Generalforsamlingen avholdes som et digitalt møte hvor aksjonærer kan stemme elektronisk via Lumi-plattformen. Det er også mulig å forhåndsstemme eller å gi fullmakt. Innkalling til generalforsamling og alle relevante dokumenter er publisert på www.havilavoyages.com/nb/ir. Ytterligere informasjon finnes i innkallingen til generalforsamling som er vedlagt. Kontakter: Administrerende direktør: Bent Martini, +47 905 99 650 Finansdirektør: Aleksander Røynesdal, + 47 413 18 114 Vedlegg HKY_Notice of Annual General Meeting 30 May 2024

Havila Kystruten AS: Notice of Annual General Meeting 30 May 202416.5.2024 11:19:34 CEST | Press release

The Board of Directors of Havila Kystruten AS hereby gives notice of the Annual General Meeting. The meeting will take place on Thursday, 30th May 2024 at 14:00 CEST. The Annual General Meeting will be held as a digital meeting with electronic voting via Lumi platform. It is also possible to cast votes or give proxy authorizations in advance. Notice of the Annual General Meeting together with all relevant documents is available at www.havilavoyages.com/nb/ir. Further information can be found in the notice of the Annual General Meeting which is attached hereto. Contacts: Chief Executive Officer: Bent Martini, +47 905 99 650 Chief Financial Officer: Aleksander Røynesdal, +47 413 18 114 Attachment HKY_Notice of Annual General Meeting 30 May 2024

Coloplast A/S - Invitation to Coloplast's Meet the Management event on 6 June 2024 (gentle reminder)16.5.2024 11:09:40 CEST | Press release

The event will take place on Thursday, 6 June 2024 at Coloplast’s Headquarters Holtedam 3, 3050 Humlebaek, Denmark from 11.30 - 18.00 CEST (Central European Summer Time) Coloplast invites institutional investors, equity analysts and media to attend our 2024 Meet the Management event. The event will be held in person at our headquarters in Humlebaek, Denmark, with the option to join us virtually for the plenary session. The purpose of the event is to provide participants with the opportunity to meet Coloplast’s Executive Management and other members of senior management. The day will start with a plenary session, covering a brief presentation of our H1 2023/24 results, an update on our Strive25 strategy and a dedicated session on the recent acquisition of Kerecis. In the afternoon, participants will be split into groups and rotate between four Q&A breakout sessions. Participation in the breakout sessions will be in-person only. The formal program will end at 18.00, followed by an opport

Indfrielse af kapitalinstrumenter16.5.2024 11:02:34 CEST | pressemeddelelse

Selskabsmeddelelse nr. 24/2024 Holbæk, den 16. maj 2024 Indfrielse af kapitalinstrumenter Sparekassen Sjælland-Fyn A/S har dags dato truffet beslutning om indfrielse af supplerende kapital på DKK 150 mio. Den supplerende kapital, der er udstedt den 21. juni 2019 (ISIN: DK0030444914), indfries den 21. juni 2024. Indfrielsen sker som led i sparekassens kapitalplaner samt efter forudgående tilladelse fra Finanstilsynet. Med venlig hilsen Lars Petersson Jakob Andersson Adm. direktør Bestyrelsesformand Yderligere information: Presse- og direktionsrådgiver Morten Huse Eikrem-Jeppesen, tlf. 53 85 07 70 Administrerende direktør Lars Petersson Sparekassedirektør Lars Bolding www.spks.dk/ir Vedhæftet fil Selskabsmeddelelse nr. 24 - 2024 Indfrielse af kapitalinstrumenter

HiddenA line styled icon from Orion Icon Library.Eye